| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6414cf0912e2737a41f574e3435772e3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2019-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0450c3ddf9f41834f83259a078e22a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_466822aa14635449d9dcad133ff11e15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f764c2ab2a2564f45a583b1becbfb35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed43ef4fb515a227705f1d855aeb1430 |
| publicationDate |
2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202002964-A |
| titleOfInvention |
Use of CDK4/6 inhibitor in combination with EGFR inhibitor for preparation of medicament for treating tumor diseases |
| abstract |
The present invention provides an use of a CDK4/6 inhibitor in combination with an EGFR inhibitor for a manufacture of a medicament for a treatment of neoplastic diseases. In particular, the present invention provides the use of a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) in combination with a human epidermal growth factor receptor inhibitor (EGFRi) for the preparation of the medicament for preventing or treating a neoplastic disease. |
| priorityDate |
2018-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |